Biotech · Private company
Kedrion S.p.A.
Track this companyFree. Adds Kedrion S.p.A. to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Human PlasminogenPhase 3 · Ligneous ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
- Immune globulin (human) 10% solution for intravenous administrationPhase 3 · Chronic Inflammatory Demyelinating PolyneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- Kedrion IVIG 10%Phase 3 · Chronic Primary Immune Thrombocytopenia (ITP)ClinicalTrials.gov · fetched Nov 12, 2026
- Kedrion IVIG 10%Phase 3 · Primary ImmunodeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Kedrion IVIG 10%Phase 3 · Primary Immunodeficiency DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Kedbumin 25%HypovolemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)PHASE3 · RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT06752356 · fetched Nov 12, 2026
- A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)PHASE3 · RECRUITING · started Aug 13, 2025ClinicalTrials.gov NCT07059000 · fetched Nov 12, 2026
- Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)PHASE3 · ACTIVE_NOT_RECRUITING · started Mar 31, 2021ClinicalTrials.gov NCT04944979 · fetched Nov 12, 2026
- Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID PatientsPHASE3 · COMPLETED · started Apr 30, 2019ClinicalTrials.gov NCT03961009 · fetched Nov 12, 2026
- Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to RabiesPHASE3 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02912845 · fetched Nov 12, 2026
- Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric PatientsPHASE4 · TERMINATED · started Feb 5, 2015ClinicalTrials.gov NCT01531803 · fetched Nov 12, 2026
- Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis PatientsPHASE2_PHASE3 · COMPLETED · started May 22, 2013ClinicalTrials.gov NCT01554956 · fetched Nov 12, 2026
- Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)PHASE3 · COMPLETED · started Nov 12, 2012ClinicalTrials.gov NCT01581593 · fetched Nov 12, 2026